1.9 µm Vela激光整块经尿道切除术治疗非肌层浸润性膀胱癌的安全性与疗效
该回顾性研究比较了1.9 µm Vela激光整块经尿道切除术(n=26)与常规经尿道膀胱肿瘤切除术(n=44)治疗原发性非肌层浸润性膀胱癌。激光组病理分期标本合格率更高,术中无闭孔神经反射和膀胱穿孔,常规组分别有7例和3例发生(P<.05)。激光组术后持续膀胱冲洗时间更短,两组手术时间和输血率无显著差异,随访期间总复发率无显著差异。
要点
- 激光组病理分期标本合格率高于常规组。
- 激光组术中无闭孔神经反射和膀胱穿孔,常规组分别有7例和3例。
- 激光组术后持续膀胱冲洗时间短于常规组。
核心结论
- 1.9 µm Vela激光整块经尿道切除术在减少术中并发症、提高病理评估标本质量及缩短术后持续膀胱冲洗时间方面优于常规经尿道膀胱肿瘤切除术。
研究设计与样本
- 回顾性分析比较1.9 µm Vela激光整块经尿道切除术(n=26)与常规经尿道膀胱肿瘤切除术(n=44)治疗原发性非肌层浸润性膀胱癌患者的数据。
主要发现
- 激光组病理分期标本合格率高于常规组。
- 激光组术中无闭孔神经反射和膀胱穿孔,常规组有7例闭孔神经反射和3例膀胱穿孔(P<.05)。
- 两组手术时间和输血率无显著差异。
- 激光组术后持续膀胱冲洗时间短于常规组。
- 随访期间两组总复发率无显著差异。
临床怎么用
- 对于原发性非肌层浸润性膀胱癌,可考虑采用1.9 µm Vela激光整块经尿道切除术以降低术中闭孔神经反射和膀胱穿孔风险,并缩短术后持续膀胱冲洗时间。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the safety and efficacy of 1.9 µm Vela laser in treatment of primary non-muscle-invasive bladder cancer. METHODS: The data of the patients with non-muscle-invasive bladder cancer treated by either en bloc transurethral resection with 1.9 µm Vela laser (n = 26) or conventional transurethral resection of bladder tumor (n = 44) were analyzed retrospectively. The preoperative characteristics and intraoperative complications were compared in the 2 groups. RESULTS: Patients who were treated by 1.9 µm Vela laser obtained a higher rate of specimens meeting the requirements of pathologic assessment for tumor staging compared with the patients treated by conventional transurethral resection of bladder tumor. No obturator nerve reflex and bladder perforation occurred during surgery in the 1.9 µm Vela laser group. However, 7 patients in the conventional transurethral resection of bladder tumor group encountered obturator nerve reflex, and 3 of them encountered bladder perforation (P <.05). There were no significant differences between the 2 groups in operative duration and transfusion rate. Patients in the 1.9 µm Vela laser group had shorter postoperative continuous bladder irrigation time than that in the conventional transurethral resection of bladder tumor group. There was no significant difference in the overall recurrence rate between the 2 groups during the follow-up periods. CONCLUSION: En bloc transurethral resection with 1.9 µm Vela laser in the treatment of non-muscle-invasive bladder cancer demonstrates an advantage over conventional transurethral resection of bladder tumor in reducing intraoperative complications, improving the quality of the specimens admitted for pathologic assessment, and shortening the duration of postoperative continuous bladder irrigation.
引用
- Xu H, Ma J, Chen Z, et al. Safety and Efficacy of En Bloc Transurethral Resection With 1.9 µm Vela Laser for Treatment of Non-Muscle-invasive Bladder Cancer. Urology. 2017. PMID: 29198850. doi:10.1016/j.urology.2017.11.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。